Cite
Reddel HK, Bacharier LB, Bateman ED, et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021;doi: 10.1016/j.jaip.2021.10.001.
Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., Cruz, A. A., Duijts, L., Drazen, J. M., FitzGerald, J. M., Fleming, L. J., Inoue, H., Ko, F. W., Krishnan, J. A., Levy, M. L., Lin, J., Mortimer, K., Pitrez, P. M., Sheikh, A., Yorgancioglu, A. A., & Boulet, L. P. (2021). Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. The journal of allergy and clinical immunology. In practice, . https://doi.org/10.1016/j.jaip.2021.10.001
Reddel, Helen K, et al. "Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes." The journal of allergy and clinical immunology. In practice vol. (2021). doi: https://doi.org/10.1016/j.jaip.2021.10.001
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021 Oct 27; doi: 10.1016/j.jaip.2021.10.001. Epub 2021 Oct 27. PMID: 34718211.
Copy
Download .nbib